Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma

NCT01063907

Conditions
Blood Protein Disorders, Bronchial Diseases, Bronchiolitis, +28 more
Locations
  • Arizona Clinical Research Center, Inc. / Arizona Oncology Associates, 1825 N Kolb, Tucson, Arizona, United States
  • Pacific Shores Medical Group 1043 Elm Ave, Suite 104 Long Beach, California, United States
  • UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333, Los Angeles, California, United States
  • Collaborative Research Group 2320 S Seacrest Blvd, Suite 202 Boynton Beach, Florida, United States
View all 26 locations
View Trial Details
Completed

A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

NCT00457782

Conditions
B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, Bronchial Diseases, +31 more
Locations
  • St Bartholomew's Hospital London, United Kingdom
  • UCLH London, United Kingdom
  • Christie Hospital Manchester, United Kingdom
  • Nottingham University NHS Trust Nottingham, United Kingdom
View Trial Details
Completed

KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)

NCT01626664

Conditions
Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Miami / Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • National Cancer Institute Bethesda, Maryland, United States
View all 20 locations
View Trial Details
Completed

Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL

NCT04524455

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
View all 19 locations
View Trial Details

Related conditions